Cipla receives final approval for the generic version of Somatuline Depot Injection
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
Launch of 20 new medicines expected by 2030
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
EBITDA before special items falls 1.3 percent to € 4.41 billion
Lupin updates on shipment of Mirabegron ER Tablets
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Sales reflect continued strong growth in oncology and vaccines
Subscribe To Our Newsletter & Stay Updated